Adipose and non-adipose layers of epicardium: paracrine activity consequences on cardiomyocytes and modulation by semaglutide
Event: ESC Congress 2025
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Session: Lipid metabolism, vascular function, and novel strategies in atherosclerosis prevention
Differential released proteins between epicardial and subcutaneous fat from patients with cardiovascular disease: role on its progression and semaglutide modulation
Event: ESC Congress 2025
Topic: Biomarkers
Session: Neuro-immune-adipose interactions in cardiovascular dysfunction and arrhythmia
Semaglutide modulates pro-inflammatory neutrophil phenotype induced by supraphysiological levels of the adipokine FABP4 in patients with cardiovascular disease.
Event: ESC Congress 2024
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Session: Antidiabetic drugs for treatment of cardiovascular disease
Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.
Event: ESC Congress 2024
Topic: Metabolism
Session: Adipose tissue and other metabolic interactions
